News Focus
News Focus
Followers 48
Posts 7119
Boards Moderated 0
Alias Born 06/17/2009

Re: Penny Double post# 138821

Saturday, 01/27/2018 8:10:40 AM

Saturday, January 27, 2018 8:10:40 AM

Post# of 518935
Thanks, PD, for the link, which provides a web site for volunteering in forthcoming Alzheimer's studies. I'll be signing up later today.

With Dr. Aisen as one of the three lead investigators (see below from NIH PR on 12/11/17) and a SAB member at Anavex, will he be able to put his history with Lilly, sola and amyloid ("Lilly prodded by Paul Aisen" was a quote I read recently) behind him to allow for him to accept new ideas on Alzheimer's drugs? Be good to read his current views on 2-73.


Trials would be conducted harnessing guidance from ACTC leaders, an executive committee and an external advisory board, which will include a patient advocate. The Principal Investigators for the project are:

Paul Stephen Aisen, M.D., director of the ATRI at the Keck School of Medicine of USC, San Diego
Reisa A. Sperling, M.D., director of the Center for Alzheimer Research and Treatment at the Brigham and Women’s Hospital, professor of Neurology, Harvard Medical School, Boston
Ronald C. Petersen, M.D., Ph.D., director of the Mayo Clinic Alzheimer’s Disease Research Center, professor of Neurology at Mayo Clinic College of Medicine and Science, Rochester, Minnesota

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News